10-Q 1 form10q.htm BERRY GLOBAL GROUP 10Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 2, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 001-35672
graphic

BERRY GLOBAL GROUP, INC.

A Delaware corporation
 101 Oakley Street, Evansville, Indiana, 47710
(812) 424-2904
 IRS employer identification number
20-5234618

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
BERY
New York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer 
Accelerated Filer
Non-Accelerated Filer
Smaller Reporting Company
Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    No 

There were 130.3 million shares of common stock outstanding at May 5, 2022.




CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

Information included or incorporated by reference in Berry Global Group, Inc.’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contains or may contain forward-looking statements.  This report includes “forward-looking” statements with respect to our financial condition, results of operations and business and our expectations or beliefs concerning future events.  These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “project,” “outlook,” “anticipates” or “looking forward” or similar expressions that relate to our strategy, plans, intentions, or expectations.  All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements.  In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments.  These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.  All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Additionally, we caution readers that the list of important factors discussed in our most recent Form 10-K in the section titled “Risk Factors” may not contain all of the material factors that are important to you.  In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this report may not in fact occur.  Accordingly, readers should not place undue reliance on those statements.

2

Berry Global Group, Inc.
Form 10-Q Index
For Quarterly Period Ended April 2, 2022

Part I.
Financial Information
Page No.
 
Item 1.
Financial Statements:
 
   
4
   
5
   
6
   
7
   
8
 
Item 2.
15
 
Item 3.
22
 
Item 4.
23
Part II.
Other Information
 
 
Item 1.
24
 
Item 1A.
24
 
Item 2.
24
 
Item 6.
25
 
26


3

Part I. Financial Information

Item 1.
Financial Statements
Berry Global Group, Inc.
Consolidated Statements of Income
(Unaudited)
(in millions of dollars, except per share amounts)

   
Quarterly Period Ended
   
Two Quarterly Periods Ended
 
   
April 2, 2022
   
April 3, 2021
   
April 2, 2022
   
April 3, 2021
 
Net sales
 
$
3,775
   
$
3,370
   
$
7,348
   
$
6,506
 
Costs and expenses:
                               
Cost of goods sold
   
3,154
     
2,706
     
6,192
     
5,224
 
Selling, general and administrative
   
207
     
220
     
442
     
461
 
Amortization of intangibles
   
65
     
73
     
133
     
147
 
Restructuring and transaction activities
   
8
     
38
     
11
     
37
 
Operating income
   
341
     
333
     
570
     
637
 
Other expense
   
6
     
6
     
6
     
31
 
Interest expense
   
71
     
84
     
142
     
181
 
Income before income taxes
   
264
     
243
     
422
     
425
 
Income tax expense
   
59
     
62
     
96
     
114
 
Net income
 
$
205
   
$
181
   
$
326
   
$
311
 
                                 
Net income per share:
                               
Basic
 
$
1.53
   
$
1.35
   
$
2.42
   
$
2.32
 
Diluted
   
1.50
     
1.32
     
2.36
     
2.28
 






Consolidated Statements of Comprehensive Income
(Unaudited)
(in millions of dollars)

   
Quarterly Period Ended
   
Two Quarterly Periods Ended
 
   
April 2, 2022
   
April 3, 2021
   
April 2, 2022
   
April 3, 2021
 
Net income
 
$
205
   
$
181
   
$
326
   
$
311
 
Other comprehensive income, net of tax:
                               
Currency translation
   
37
     
(73
)
   
15
     
105
 
Derivative instruments
   
71
     
54
     
100
     
71
 
Other comprehensive income (loss)
   
108
     
(19
)
   
115
     
176
 
Comprehensive income
 
$
313
   
$
162
   
$
441
   
$
487
 

See notes to consolidated financial statements.

4

Berry Global Group, Inc.
Consolidated Balance Sheets
(in millions of dollars)

   
April 2, 2022
   
October 2, 2021
 
   
(Unaudited)
       
Assets
           
Current assets:
           
Cash and cash equivalents
 
$
622
   
$
1,091
 
Accounts receivable
   
1,996
     
1,879
 
Finished goods
   
1,032
     
960
 
Raw materials and supplies
   
932
     
947
 
Prepaid expenses and other current assets
   
401
     
217
 
Total current assets
   
4,983
     
5,094
 
Noncurrent assets:
               
Property, plant and equipment
   
4,650
     
4,677
 
Goodwill and intangible assets
   
7,183
     
7,434
 
Right-of-use assets
   
536
     
562
 
Other assets
   
183
     
115
 
Total assets
 
$
17,535
   
$
17,882
 
                 
                 
Liabilities and stockholders’ equity
               
Current liabilities:
               
Accounts payable
 
$
1,651
   
$
2,041
 
Accrued employee costs
   
250
     
336
 
Other current liabilities
   
824
     
788
 
Current portion of long-term debt
   
19
     
21
 
Total current liabilities
   
2,744
     
3,186
 
Noncurrent liabilities:
               
Long-term debt
   
9,627
     
9,439
 
Deferred income taxes
   
569
     
568
 
Employee benefit obligations
   
244
     
276
 
Operating lease liabilities
   
443
     
466
 
Other long-term liabilities
   
588
     
767
 
Total liabilities
   
14,215
     
14,702
 
                 
Stockholders’ equity:
               
Common stock (130.4 and 135.5 million shares issued, respectively)
   
1
     
1
 
Additional paid-in capital
   
1,174
     
1,134
 
Retained earnings
   
2,326
     
2,341
 
Accumulated other comprehensive loss
   
(181
)
   
(296
)
Total stockholders’ equity
   
3,320
     
3,180
 
Total liabilities and stockholders’ equity
 
$
17,535
   
$
17,882
 

See notes to consolidated financial statements.

5

Berry Global Group, Inc.
Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited)
(in millions of dollars)

 
Quarterly Period Ended
 
Common
Stock
   
Additional
Paid-in Capital
   
Accumulated Other
Comprehensive Loss
   
Retained
Earnings
   
Total
 
Balance at January 1, 2022
 
$
1
   
$
1,170
   
$
(289
)
 
$
2,412
   
$
3,294
 
Net income
   
     
     
     
205
     
205
 
Other comprehensive income
   
     
     
108
     
     
108
 
Share-based compensation
   
     
7
     
     
     
7
 
Proceeds from issuance of common stock
   
     
6
     
     
     
6
 
Common stock repurchased and retired
   
     
(9
)
   
     
(291
)
   
(300
)
Balance at April 2, 2022
 
$
1
   
$
1,174
   
$
(181
)
 
$
2,326
   
$
3,320
 
                                         
Balance at January 2, 2021
 
$
1
   
$
1,062
   
$
(356
)
 
$
1,738
   
$
2,445
 
Net income
   
     
     
     
181
     
181
 
Other comprehensive loss
   
     
     
(19
)
   
     
(19
)
Share-based compensation
   
     
7
     
     
     
7
 
Proceeds from issuance of common stock
   
     
32
     
     
     
32
 
Balance at April 3, 2021
 
$
1
   
$
1,101
   
$
(375
)
 
$
1,919
   
$
2,646
 

 
Two Quarterly Periods Ended
 
Common
Stock
   
Additional
Paid-in Capital
   
Accumulated Other
Comprehensive Loss
   
Retained
Earnings
   
Total
 
Balance at October 2, 2021
 
$
1
   
$
1,134
   
$
(296
)
 
$
2,341
   
$
3,180
 
Net income
   
     
     
     
326
     
326
 
Other comprehensive income
   
     
     
115
     
     
115
 
Share-based compensation
   
     
28
     
     
     
28
 
Proceeds from issuance of common stock
   
     
22
     
     
     
22
 
Common stock repurchased and retired
   
     
(10
)
   
     
(341
)
   
(351
)
Balance at April 2, 2022
 
$
1
   
$
1,174
   
$
(181
)
 
$
2,326
   
$
3,320
 
                                         
Balance at September 26, 2020
 
$
1
   
$
1,034
   
$
(551
)
 
$
1,608
   
$
2,092
 
Net income
   
     
     
     
311
     
311
 
Other comprehensive income
   
     
     
176
     
     
176
 
Share-based compensation
   
     
28
     
     
     
28
 
Proceeds from issuance of common stock
   
     
39
     
     
     
39
 
Balance at April 3, 2021
 
$
1
   
$
1,101
   
$
(375
)
 
$
1,919
   
$
2,646
 


See notes to consolidated financial statements.

6

Berry Global Group, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
(in millions of dollars)

   
Two Quarterly Periods Ended
 
   
April 2, 2022
   
April 3, 2021
 
Cash Flows from Operating Activities:
           
Net income
 
$
326
   
$
311
 
Adjustments to reconcile net cash from operating activities:
               
Depreciation
   
284
     
280
 
Amortization of intangibles
   
133
     
147
 
Non-cash interest expense
   
8
     
16
 
Deferred income tax
   
(43
)
   
(28
)
Share-based compensation expense
   
28
     
28
 
Other non-cash operating activities, net
   
(14
)
   
51
 
Changes in working capital
   
(714
)
   
(156
)
Changes in other assets and liabilities
   
(22
)
   
(11
)
Net cash from operating activities
   
(14
)
   
638
 
                 
Cash Flows from Investing Activities:
               
Additions to property, plant and equipment, net
   
(367
)
   
(364
)
Divestiture of business
   
3
     
143
 
Net cash from investing activities
   
(364
)
   
(221
)
                 
Cash Flows from Financing Activities:
               
Proceeds from long-term borrowings
   
244
     
2,316
 
Repayments on long-term borrowings
   
(9
)
   
(2,683
)
Proceeds from issuance of common stock
   
22
     
39
 
Repurchase of common stock
   
(351
)
   
 
Debt financing costs
   
     
(16
)
Net cash from financing activities
   
(94
)
   
(344
)
Effect of currency translation on cash
   
3
     
20
 
Net change in cash and cash equivalents
   
(469
)
   
93
 
Cash and cash equivalents at beginning of period
   
1,091
     
750
 
Cash and cash equivalents at end of period
 
$
622
   
$
843
 

See notes to consolidated financial statements.

7

Berry Global Group, Inc.
Notes to Consolidated Financial Statements
(Unaudited)
(tables in millions of dollars, except per share data)


1.  Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. (“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statementsIn preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period.  Actual results could differ from those estimates.  The Company’s U.S. based results for fiscal 2022 and fiscal 2021 are based on a fifty-two and fifty-three week period, respectively.  The extra week in fiscal 2021 occurred in the first quarter.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated.  For further information, refer to the Company’s most recent Form 10-K filed with the Securities and Exchange Commission.


2.  Recent Accounting Pronouncements

Reference Rate Reform

In 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848).  This standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR.  ASU 2020-04 is effective upon issuance and generally can be applied through the end of calendar year 2022.  The Company is currently evaluating the impact and whether it plans to adopt the optional expedients and exceptions provided under this new standard.

3.  Revenue and Accounts Receivable


Our revenues are primarily derived from the sale of non-woven, flexible and rigid products to customers.  Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration to which the Company expects to be entitled.  We consider the promise to transfer products to be our sole performance obligation.  If the consideration agreed to in a contract includes a variable amount, we estimate the amount of consideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method.  Our main source of variable consideration is customer rebates.  There are no material instances where variable consideration is constrained and not recorded at the initial time of sale.  Generally, our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer.  The accrual for customer rebates was $101 million and $104 million at April 2, 2022 and October 2, 2021, respectively, and is included in Other current liabilities on the Consolidated Balance Sheets.  The Company disaggregates revenue based on reportable business segment, geography, and significant product line.  Refer to Note 10. Segment and Geographic Data for further information.


Accounts receivable are presented net of allowance for credit losses of $19 million and $21 million at April 2, 2022 and October 2, 2021, respectively.  The Company records its current expected credit losses based on a variety of factors including historical loss experience and current customer financial condition.  The changes to our current expected credit losses, write-off activity, and recoveries were not material for any of the periods presented.


The Company has entered into various factoring agreements, including customer-based supply chain financing programs, to sell certain receivables to third-party financial institutions.  Agreements which result in true sales of the transferred receivables, which occur when receivables are transferred without recourse to the Company, are reflected as a reduction of accounts receivable on the consolidated balance sheets and the proceeds are included in the cash flows from operating activities in the consolidated statements of cash flows.  The fees associated with the transfer of receivables for all programs were not material for any of the periods presented.

8



4.  Disposition

During fiscal 2022, the Company reached an initial agreement to sell our roto molding business which is operated in the Consumer Packaging International segment for expected proceeds of $114 million, which is preliminary and subject to adjustment at closing.  The Company reported fiscal 2021 net sales of $146 million related to the business.  For the period ended April 2, 2022, the Company classified assets of $156 million and liabilities of $49 million as held for sale.  The assets and liabilities held for sale are recorded in Prepaid expenses and other current assets, and Other current liabilities, respectively, on the Consolidated Balance Sheets. 

5.  Restructuring and Transaction Activities

The table below includes the significant components of restructuring and transaction activities, by reporting segment:

   
Quarterly Period Ended
   
Two Quarterly Periods Ended
 
   
April 2, 2022
   
April 3, 2021
   
April 2, 2022
   
April 3, 2021
 
Consumer Packaging International
 
$
5
   
$
38
   
$
7
   
$
41
 
Consumer Packaging North America
   
2
     
     
3
     
1
 
Health, Hygiene & Specialties
   
     
     
(1
)
   
 
Engineered Materials
   
1
     
     
2
     
(5
)
Consolidated
 
$
8
   
$
38
   
$
11
   
$
37
 

The table below sets forth the activity with respect to the restructuring and transaction activities accrual at April 2, 2022:

 
Restructuring
             
   
Employee Severance
and Benefits
   
Facility
Exit Costs
   
Transaction
Activities
   
Total
 
Balance as of October 2, 2021
 
$
6
   
$
5
   
$
   
$
11
 
Charges
   
3
     
6
     
2
     
11
 
Cash
   
(3
)
   
(7
)
   
(2
)
   
(12
)
Balance as of April 2, 2022
 
$
6
   
$
4
   
$
   
$
10
 

6.  Leases

The Company leases certain manufacturing facilities, warehouses, office space, manufacturing equipment, office equipment, and automobiles.

We recognize right-of-use assets and lease liabilities for leases with original lease terms greater than one year based on the present value of lease payments over the lease term using our incremental borrowing rate on a collateralized basis.  Short-term leases, with original lease terms of less than one year, are not recognized on the balance sheet.  We are party to certain leases, namely for manufacturing facilities, which offer renewal options to extend the original lease term.  Renewal options are included in the right-of-use asset and lease liability based on our assessment of the probability that the options will be exercised.

Supplemental lease information is as follows:

Leases
Classification
 
April 2, 2022
   
October 2, 2021
 
Operating leases:
             
Operating lease right-of-use assets
Right-of-use assets
 
$
536
   
$
562
 
Current operating lease liabilities
Other current liabilities
   
110
     
113
 
Noncurrent operating lease liabilities
Operating lease liability
   
443
     
466
 
Finance leases:
                 
Finance lease right-of-use assets
Property, plant, and equipment, net
 
$
47
   
$
57
 
Current finance lease liability
Current portion of long-term debt
   
13
     
14
 
Noncurrent finance lease liabilities
Long-term debt, less current portion
   
30
     
38
 

9


         
Two Quarterly Periods Ended
 
Lease Type
Cash Flow Classification
 
Lease Expense Category
   
April 2, 2022
   
April 3, 2021
 
Operating
Operating
 
Lease cost
   
$
62
   
$
57
 
Finance
Operating
 
Interest expense
     
1
     
1
 
Finance
Financing
 
-
     
9
     
16
 
Finance
-
 
Amortization of right-of-use assets
     
5
     
7
 

Right-of-use assets obtained in exchange for new operating lease liabilities were $9 million and $21 million for the quarterly and two quarterly periods ended April 2, 2022, respectively.

7.  Long-Term Debt

Long-term debt consists of the following:

Facility
Maturity Date
 
April 2, 2022
   
October 2, 2021
 
Term loan
July 2026
 
$
3,440
     
3,440
 
Revolving line of credit
May 2024
   
244
     
 
0.95% First Priority Senior Secured Notes
February 2024
   
800
     
800
 
1.00% First Priority Senior Secured Notes (a)
July 2025
   
776
     
810
 
1.57% First Priority Senior Secured Notes
January 2026
   
1,525
     
1,525
 
4.875% First Priority Senior Secured Notes
July 2026
   
1,250
     
1,250
 
1.65% First Priority Senior Secured Notes
January 2027
   
400
     
400
 
1.50% First Priority Senior Secured Notes (a)
July 2027
   
416
     
434
 
4.50% Second Priority Senior Secured Notes
February 2026
   
300
     
300
 
5.625% Second Priority Senior Secured Notes
July 2027
   
500
     
500
 
Debt discounts and deferred fees
     
(69
)
   
(77
)
Finance leases and other
Various
   
64
     
78
 
Total long-term debt
     
9,646
     
9,460
 
Current portion of long-term debt
     
(19
)
   
(21
)
Long-term debt, less current portion
   
$
9,627
     
9,439
 
(a)
Euro denominated 

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net on the Consolidated Statements of Income through maturity. 


8.  Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors.  The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies.  These financial instruments are not used for trading or other speculative purposes.

Cross-Currency Swaps

The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk.  The swap agreements mature May 2022 (€250 million), June 2024 (€1,625 million) and July 2027 (£700 million).  In addition to cross-currency swaps, we hedge a portion of our foreign currency risk by designating foreign currency denominated long-term debt as net investment hedges of certain foreign operations.  As of April 2, 2022, we had outstanding long-term debt of €785 million that was designated as a hedge of our net investment in certain euro-denominated foreign subsidiaries.  When valuing cross-currency swaps the Company utilizes Level 2 inputs (substantially observable).
10


Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt.  When valuing interest rate swaps the Company utilizes Level 2 inputs (substantially observable).

As of April 2, 2022, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.398%, with an expiration in June 2026, (ii) a $400 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.916% with an expiration in June 2026, (iii) a $884 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.857%, with an expiration in June 2024, and (iv) a $473 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.050%, with an expiration in June 2024.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:

Derivative Instruments
Hedge Designation
Balance Sheet Location
 
April 2, 2022
   
October 2, 2021
 
Cross-currency swaps
Designated
Other long-term liabilities
 
$
222
   
$
323
 
Interest rate swaps
Designated
Other assets
   
45
     
 
Interest rate swaps
Designated
Other long-term liabilities
   
     
82
 
Interest rate swaps
Not designated
Other assets
   
26
     
 
Interest rate swaps
Not designated
Other long-term liabilities
   
68
     
49
 

The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows:

   
Quarterly Period Ended
   
Two Quarterly Periods Ended
 
Derivative Instruments
 Statements of Income Location
 
April 2, 2022
   
April 3, 2021
   
April 2, 2022
   
April 3, 2021
 
Cross-currency swaps
Interest expense
 
$
(4
)
 
$
(1
)
 
$
(7
)
 
$
(4
)
Interest rate swaps
Interest expense
   
12
     
17
     
24
     
34
 

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition.  The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values.  The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value.  These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment.  The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist.  The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2021 assessment.  No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of April 2, 2022 and October 2, 2021, along with the impairment loss recognized on the fair value measurement during the period:

   
As of April 2, 2022
 
   
Level 1
   
Level 2
   
Level 3
   
Total
   
Impairment
 
Indefinite-lived trademarks
 
$
   
$
   
$
248
   
$
248
   
$
 
Goodwill
   
     
     
5,091
     
5,091
     
 
Definite lived intangible assets
   
     
     
1,844
     
1,844
     
 
Property, plant, and equipment
   
     
     
4,650
     
4,650
     
 
Total
 
$
   
$
   
$
11,833
   
$
11,833
   
$
 

11


   
As of October 2, 2021
 
   
Level 1
   
Level 2
   
Level 3
   
Total
   
Impairment
 
Indefinite-lived trademarks
 
$
   
$
   
$
248
   
$
248
   
$
 
Goodwill
   
     
     
5,192
     
5,192
     
 
Definite lived intangible assets
   
     
     
1,994
     
1,994
     
 
Property, plant, and equipment
   
     
     
4,677
     
4,677
     
1
 
Total
 
$
   
$
   
$
12,111
   
$
12,111
   
$
1
 

The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and finance lease obligations.  The book value of our marketable long-term indebtedness exceeded fair value by $212 million as of April 2, 2022.  The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable). 

9.  Income Taxes

In comparison to the statutory rate, the higher effective tax rate for the quarter was negatively impacted by state taxes and global intangible low-taxed income provisions, partially offset by other discrete items.

10.  Segment and Geographic Data

The Company’s operations are organized into four reporting segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Engineered Materials.  The structure is designed to align us with our customers, provide optimal service, drive future growth, and to facilitate synergies realization.

Selected information by reportable segment is presented in the following tables:

 
Quarterly Period Ended
   
Two Quarterly Periods Ended
 
   
April 2, 2022
   
April 3, 2021
   
April 2, 2022
   
April 3, 2021
 
Net sales:
                       
Consumer Packaging International
 
$
1,139
   
$
1,060
   
$
2,195
   
$
2,048
 
Consumer Packaging North America
   
880
     
731
     
1,732
     
1,417
 
Health, Hygiene & Specialties
   
822
     
781
     
1,640
     
1,521
 
Engineered Materials
   
934
     
798
     
1,781
     
1,520
 
Total net sales
 
$
3,775
   
$
3,370
   
$
7,348
   
$
6,506
 
Operating income:
                               
Consumer Packaging International
 
$
97
   
$
59
   
$
166
   
$
135
 
Consumer Packaging North America
   
85
     
77
     
131
     
136
 
Health, Hygiene & Specialties
   
69
     
114
     
131
     
210
 
Engineered Materials
   
90
     
83
     
142
     
156
 
Total operating income
 
$
341
   
$
333
   
$
570
   
$
637
 
Depreciation and amortization:
                               
Consumer Packaging International
 
$
82
   
$
87
   
$
164
   
$
171
 
Consumer Packaging North America
   
53
     
54
     
107
     
110
 
Health, Hygiene & Specialties
   
44
     
42
     
89
     
87
 
Engineered Materials
   
27
     
29
     
57
     
59
 
 Total depreciation and amortization
 
$
206
   
$
212
   
$
417
   
$
427
 

12


Selected information by geographical region is presented in the following tables:

 
Quarterly Period Ended
   
Two Quarterly Periods Ended
 
   
April 2, 2022
   
April 3, 2021
   
April 2, 2022
   
April 3, 2021
 
Net sales:
                       
United States and Canada
 
$
1,996
   
$
1,728
   
$
3,948
   
$
3,405
 
Europe
   
1,399
     
1,257
     
2,616
     
2,350
 
Rest of world
   
380
     
385
     
784
     
751
 
Total net sales
 
$
3,775
   
$
3,370
   
$
7,348
   
$
6,506
 

11.  Contingencies and Commitments

The Company is party to various legal proceedings involving routine claims which are incidental to its business.  Although the Company’s legal and financial liability with respect to such proceedings cannot be estimated with certainty, we believe that any ultimate liability would not be material to our financial statements.

The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

12.  Share Repurchase Program

During the quarterly period ended April 2, 2022, the Company repurchased and retired 5,029 thousand shares for $300 million.  For the two quarterly periods ended April 2, 2022, the Company repurchased and retired 5,756 thousand shares for $351 million.  Authorized share repurchases of $700 million remain available to the Company. 


13.  Basic and Diluted Earnings Per Share

Basic net income or earnings per share ("EPS") is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents.   Diluted EPS includes the effects of options and restricted stock units, if dilutive.

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted EPS calculations:

   
Quarterly Period Ended
   
Two Quarterly Periods Ended
 
(in millions, except per share amounts)
 
April 2, 2022
   
April 3, 2021
   
April 2, 2022
   
April 3, 2021
 
Numerator
                       
Consolidated net income
 
$
205
   
$
181
   
$
326
   
$
311
 
Denominator
                               
Weighted average common shares outstanding - basic
   
133.8
     
134.3
     
134.6
     
133.9
 
Dilutive shares
   
3.1
     
2.5
     
3.4
     
2.7
 
Weighted average common and common equivalent shares outstanding - diluted
   
136.9
     
136.8
     
138.0
     
136.6
 
                                 
Per common share earnings
                               
Basic
 
$
1.53
   
$
1.35
   
$
2.42
   
$
2.32
 
Diluted
 
$
1.50
   
$
1.32
   
$
2.36
   
$
2.28
 

1.2 million and 1.3 million shares, respectively, were excluded from the diluted EPS calculation for the quarterly and two quarterly periods ended April 2, 2022 as their effect would be anti-dilutive.  For the two quarterly periods ended April 3, 2021, 3.2 million shares were excluded. 

13


14.  Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

Quarterly Period Ended
 
Currency
Translation
   
Defined Benefit
Pension and Retiree
Health Benefit Plans
   
Derivative
Instruments
   
Accumulated Other
Comprehensive Loss
 
Balance at January 1, 2022
 
$
(176
)
 
$
(67
)
 
$
(46
)
 
$
(289
)
Other comprehensive income before reclassifications
   
37
     
     
69
     
106
 
Net amount reclassified
   
     
     
2
     
2
 
Balance at April 2, 2022
 
$
(139
)
 
$
(67
)
 
$
25
   
$
(181
)

   
Currency
Translation
   
Defined Benefit
Pension and Retiree
Health Benefit Plans
   
Derivative
Instruments
   
Accumulated Other
Comprehensive Loss
 
Balance at January 2, 2021
 
$
(100
)
 
$
(116
)
 
$
(140
)
 
$
(356
)
Other comprehensive income (loss) before reclassifications
   
(73
)
   
     
52
     
(21
)
Net amount reclassified
   
     
     
2
     
2
 
Balance at April 3, 2021
 
$
(173
)
 
$
(116
)
 
$
(86
)
 
$
(375
)

Two Quarterly Periods Ended
 
Currency
Translation
   
Defined Benefit
Pension and Retiree
Health Benefit Plans
   
Derivative
Instruments
   
Accumulated Other
Comprehensive Loss
 
Balance at October 2, 2021
 
$
(154
)
 
$
(67
)
 
$
(75
)
 
$
(296
)
Other comprehensive income before reclassifications
   
15
     
     
95
     
110
 
Net amount reclassified
   
     
     
5
     
5
 
Balance at April 2, 2022
 
$
(139
)
 
$
(67
)
 
$
25
   
$
(181
)

   
Currency
Translation
   
Defined Benefit
Pension and Retiree
Health Benefit Plans
   
Derivative
Instruments
   
Accumulated Other
Comprehensive Loss
 
Balance at September 26, 2020
 
$
(278
)
 
$
(116
)
 
$
(157
)
 
$
(551
)
Other comprehensive income before reclassifications
   
105